Nicla La Verde

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

NPJ breast cancer

Vaccines

International journal of molecular sciences

Journal of chemotherapy (Florence, Italy)

This page only lists publications with an associated author ORCID identifier.

Publications

Davide Dalu, Anna Lisa Ridolfo, Lorenzo Ruggieri, Maria Silvia Cona, Agostino Riva, Davide De Francesco, Chiara Tricella, Cinzia Fasola, Sabrina Ferrario, Anna Gambaro, Benedetta Lombardi Stocchetti, Valeria Smiroldo, Gaia Rebecchi, Sheila Piva, Giorgia Carrozzo, Spinello Antinori, Nicla La Verde
Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience. Vaccines 12 (6) (2024)
Alessandra Fabi, Luisa Carbognin, Andrea Botticelli, Ida Paris, Paola Fuso, Maria Cristina Savastano, Nicla La Verde, Carla Strina, Rebecca Pedersini, Stefania Guarino, Curigliano Giuseppe, Carmen Criscitiello, Mimma Raffaele, Alessandra Beano, Antonio Franco, Maria Rosaria Valerio, Francesco Verderame, Andrea Fontana, Eva Regina Haspinger, Alessia Caldara, Alba Di Leone, Giampaolo Tortora, Diana Giannarelli, Giovanni Scambia
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Alessandra Fabi, Luisa Carbognin, Andrea Botticelli, Ida Paris, Paola Fuso, Maria Cristina Savastano, Nicla La Verde, Carla Strina, Rebecca Pedersini, Stefania Guarino, Curigliano Giuseppe, Carmen Criscitiello, Mimma Raffaele, Alessandra Beano, Antonio Franco, Maria Rosaria Valerio, Francesco Verderame, Andrea Fontana, Eva Regina Haspinger, Alessia Caldara, Alba Di Leone, Giampaolo Tortora, Diana Giannarelli, Giovanni Scambia
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer. NPJ breast cancer 10 (1) (2024)
Davide Dalu, Anna Lisa Ridolfo, Lorenzo Ruggieri, Maria Silvia Cona, Agostino Riva, Davide De Francesco, Chiara Tricella, Cinzia Fasola, Sabrina Ferrario, Anna Gambaro, Benedetta Lombardi Stocchetti, Valeria Smiroldo, Gaia Rebecchi, Sheila Piva, Giorgia Carrozzo, Spinello Antinori, Nicla La Verde
Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience. Vaccines 12 (6) (2024)
Davide Dalu, Anna Lisa Ridolfo, Lorenzo Ruggieri, Maria Silvia Cona, Agostino Riva, Davide De Francesco, Chiara Tricella, Cinzia Fasola, Sabrina Ferrario, Anna Gambaro, Benedetta Lombardi Stocchetti, Valeria Smiroldo, Gaia Rebecchi, Sheila Piva, Giorgia Carrozzo, Spinello Antinori, Nicla La Verde
Hospital-Based Influenza and Pneumococcal Vaccination for Cancer Patients on Active Treatment and Their Family Members during the COVID-19 Pandemic in Italy: A Single-Center Experience. Vaccines 12 (6) (2024)
Lorenzo Ruggieri, Anna Moretti, Rossana Berardi, Maria Silvia Cona, Davide Dalu, Cecilia Villa, Davide Chizzoniti, Sheila Piva, Anna Gambaro, Nicla La Verde
Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians. International journal of molecular sciences 24 (5) (2023)
Alessandra Fabi, Luisa Carbognin, Andrea Botticelli, Ida Paris, Paolo Fuso, Maria Cristina Savastano, Nicla La Verde, Carla Strina, Rebecca Pedersini, Stefania Guarino, Curigliano Giuseppe, Carmen Criscitiello, Mimma Raffaele, Alessandra Beano, Antonio Franco, Maria Rosaria Valerio, Francesco Verderame, Andrea Fontana, Eva Regina Haspinger, Alessia Caldara, Alba Di Leone, Giampaolo Tortora, Diana Giannarelli, Giovanni Scambia
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer. NPJ breast cancer 9 (1) (2023)
Alessandra Fabi, Luisa Carbognin, Andrea Botticelli, Ida Paris, Paolo Fuso, Maria Cristina Savastano, Nicla La Verde, Carla Strina, Rebecca Pedersini, Stefania Guarino, Curigliano Giuseppe, Carmen Criscitiello, Mimma Raffaele, Alessandra Beano, Antonio Franco, Maria Rosaria Valerio, Francesco Verderame, Andrea Fontana, Eva Regina Haspinger, Alessia Caldara, Alba Di Leone, Giampaolo Tortora, Diana Giannarelli, Giovanni Scambia
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer. NPJ breast cancer 9 (1) (2023)
Lorenzo Ruggieri, Anna Moretti, Rossana Berardi, Maria Silvia Cona, Davide Dalu, Cecilia Villa, Davide Chizzoniti, Sheila Piva, Anna Gambaro, Nicla La Verde
Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians. International journal of molecular sciences 24 (5) (2023)
Lorenzo Ruggieri, Anna Moretti, Rossana Berardi, Maria Silvia Cona, Davide Dalu, Cecilia Villa, Davide Chizzoniti, Sheila Piva, Anna Gambaro, Nicla La Verde
Host-Related Factors in the Interplay among Inflammation, Immunity and Dormancy in Breast Cancer Recurrence and Prognosis: An Overview for Clinicians. International journal of molecular sciences 24 (5) (2023)
Davide Dalu, Cinzia Fasola, Luca Ammoni, Davide De Francesco, Maria Silvia Cona, Selene Rota, Sabrina Ferrario, Anna Gambaro, Nicoletta Tosca, Sheila Piva, Nicla La Verde
Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi's sarcoma: a real-life study. Journal of chemotherapy (Florence, Italy) 33 (5) (2021)
Veronica Franchina, Celeste Cagnazzo, Alessandro Di Costanzo, Francesca Arizio, Angela Maria Elena Frazzetto, Stefania Gori, Rosita Cenna, Fabrizio Nicolis, Giuseppe Procopio, Vincenzo Adamo, Nicla La Verde, Oriana Nanni
Patient associations and clinical oncology research: how much does a patient's voice really matter? Expert review of pharmacoeconomics & outcomes research 21 (3) (2020)
Federica Miglietta, Maria Silvia Cona, Maria Vittoria Dieci, Valentina Guarneri, Nicla La Verde
An overview of immune checkpoint inhibitors in breast cancer. Exploration of targeted anti-tumor therapy 1 (6) (2020)

Nicla La Verde.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Nicla La Verde